Tenidap
Tenidap
Tenidap (pronunciation: /tɛnɪdæp/) is a non-steroidal anti-inflammatory drug (NSAID) that was developed by Pfizer in the late 20th century. It was primarily designed for the treatment of rheumatoid arthritis and osteoarthritis, but it was withdrawn from the market due to concerns about its safety profile.
Etymology
The name "Tenidap" is a coined term, with no known etymology. It is a brand name created by the pharmaceutical company Pfizer.
Pharmacology
Tenidap belongs to the class of drugs known as NSAIDs, which work by reducing the production of prostaglandins, chemicals that cause inflammation, pain, and fever in the body. Tenidap is unique among NSAIDs in that it also inhibits the production of tumor necrosis factor (TNF), a protein involved in systemic inflammation.
Clinical Use
Tenidap was used in the treatment of rheumatoid arthritis and osteoarthritis. It was shown to be effective in reducing pain and inflammation associated with these conditions. However, it was withdrawn from the market due to concerns about its safety profile, including potential liver toxicity.
Related Terms
- Non-steroidal anti-inflammatory drug (NSAID)
- Rheumatoid arthritis
- Osteoarthritis
- Pfizer
- Tumor necrosis factor (TNF)
External links
- Medical encyclopedia article on Tenidap
- Wikipedia's article - Tenidap
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski